Patent

Dicot Pharma has a global IP strategy with a long term perspective

We have per today granted patents on various key markets within three patent families, where the most recent granted patent is valid until 2042. In addition to this, several applications within five different families has been submitted to further strengthen protection on important markets. The new patent families, once granted, will provide protection until 2045. We intend to continue to apply for further patent protection within the active ongoing IP work.

Patent families

* Patent family approved in the US. PCT applications pending for other markets.